Search Results - "Stidham, R W"

Systematic review with network meta‐analysis: the efficacy of anti‐TNF agents for the treatment of Crohn's disease by Stidham, R. W., Lee, T. C. H., Higgins, P. D. R., Deshpande, A. R., Sussman, D. A., Singal, A. G., Elmunzer, B. J., Saini, S. D., Vijan, S., Waljee, A. K.

“…Summary Background Anti‐tumour necrosis factor‐alpha agents (anti‐TNF) are effective therapies for the treatment of Crohn's disease (CD), but their comparative…”
Get full text

Systematic review with network meta‐analysis: the efficacy of anti‐tumour necrosis factor‐alpha agents for the treatment of ulcerative colitis by Stidham, R. W., Lee, T. C. H., Higgins, P. D. R., Deshpande, A. R., Sussman, D. A., Singal, A. G., Elmunzer, B. J., Saini, S. D., Vijan, S., Waljee, A. K.

“…Summary Background Antibodies against tumour necrosis factor‐alpha (anti‐TNF) are effective therapies in the treatment of ulcerative colitis (UC), but their…”
Get full text

An expert consensus to standardise definitions, diagnosis and treatment targets for anti‐fibrotic stricture therapies in Crohn's disease by Rieder, F., Bettenworth, D., Ma, C., Parker, C. E., Williamson, L. A., Nelson, S. A., van Assche, G., Di Sabatino, A., Bouhnik, Y., Stidham, R. W., Dignass, A., Rogler, G., Taylor, S. A., Stoker, J., Rimola, J., Baker, M. E., Fletcher, J. G., Panes, J., Sandborn, W. J., Feagan, B. G., Jairath, V.

“…Summary Background Fibrotic stricture is a common complication of Crohn's disease (CD) affecting approximately half of all patients. No specific anti‐fibrotic…”
Get full text

Predicting corticosteroid‐free endoscopic remission with vedolizumab in ulcerative colitis by Waljee, A. K., Liu, B., Sauder, K., Zhu, J., Govani, S. M., Stidham, R. W., Higgins, P. D. R.

“…Summary Background Vedolizumab is an effective therapy for ulcerative colitis (UC), but costly and slow to work. New clinical responses occur after 30 weeks of…”
Get full text

Editorial: visceral fat as a predictor of post‐operative recurrence of Crohn's disease by Stidham, R. W., Waljee, A. K.

“…Linked ContentThis article is linked to Holt et al papers. To view these articles visit https://doi.org/10.1111/apt.14018 and https://doi.org/10.1111/apt.14102…”
Get full text

Citrobacter rodentium Induces Tissue-Resident Memory CD4 + T Cells by Bishu, S, Hou, G, El Zaatari, M, Bishu, S R, Popke, D, Zhang, M, Grasberger, H, Zou, W, Stidham, R W, Higgins, P D R, Spence, J R, Kamada, N, Kao, J Y

“…Tissue-resident memory T cells (T cells) are a novel population of tissue-restricted antigen-specific T cells. T cells are induced by pathogens and promote…”
Get full text

Letter: biological drugs for inducing remission in ulcerative colitis – authors' reply by Stidham, R. W., Lee, T. C. H., Higgins, P. D. R., Deshpande, A. R., Sussman, D. A., Singal, A. G., Elmunzer, B. J., Saini, S. D., Vijan, S., Waljee, A. K.

Get full text

Letter: comparative efficacy of biological therapy in patients with ulcerative colitis – authors’ reply by Stidham, R. W., Lee, T. C. H., Higgins, P. D. R., Deshpande, A. R., Sussman, D. A., Singal, A. G., Elmunzer, B. J., Vijan, S., Saini, S. D., Waljee, A. K.

Get full text

P218 Over 30% of active flares in inflammatory bowel disease patients are associated with gastrointestinal infectious agents by Limsrivilai, J, Saleh, Z, Johnson, L A, Stidham, R W, Waljee, A, Gutermuth, B, Govani, S, Brown, A, Briggs, E, Rao, K, Higgins, P D

“…Abstract Background GI infections (e.g. Clostridium difficile [CDI]) can worsen inflammatory bowel disease (IBD) activity and outcomes. By conventional…”
Get full text

A randomised trial of sheathed versus standard forceps for obtaining uncontaminated biopsy specimens of microbiota from the terminal ileum by Dave, Maneesh, Johnson, Laura A, Walk, Seth T, Young, Vincent B, Stidham, Ryan W, Chaudhary, Meghana N, Funnell, Jessica, Higgins, Peter D R

“…The study of intestinal microbiota has been revolutionised by the use of molecular methods, including terminal restriction fragment length polymorphism…”
Get more information

Accuracy of Diagnostic Codes for Identifying Patients with Ulcerative Colitis and Crohn’s Disease in the Veterans Affairs Health Care System by Hou, Jason K., Tan, Mimi, Stidham, Ryan W., Colozzi, John, Adams, Devon, El-Serag, Hashem, Waljee, Akbar K.

“…Background International Classification of Diseases-9 (ICD-9) codes are useful in clinical research; however, the validity of ICD-9 codes for inflammatory…”
Get full text

Point–counterpoint: Are we overtreating patients with mild ulcerative colitis? by Waljee, Akbar K., Stidham, Ryan W., Higgins, Peter D.R., Vijan, Sandeep, Saini, Sameer D.

“…A 26 year-old man with a history of mild, left-sided ulcerative colitis presents to your clinic for a routine follow-up appointment. He initially presented…”
Get full text